(Q56832283)

5

0 references

author name string

Dirk M. Henrich

2

0 references

Martin Hoffmann

3

0 references

Andrea Honecker

4

0 references

Bettina Nauth

6

0 references

Dietmar Nagel

7

0 references

Michael Uppenkamp

The Journal of Clinical Pharmacology

8

0 references

publication date

August 2007

0 references

published in

0 references

volume

47

0 references

issue

8

0 references

page(s)

942-950

0 references

cites work

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Multiple myeloma and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Bisphosphonates: a review of their pharmacokinetic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Renal Failure with the Use of Zoledronic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Zoledronic Acid and renal toxicity: data from French adverse effect reporting database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Adverse effects of bisphosphonates. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Ibandronate: a clinical pharmacological and pharmacokinetic update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007301801